Conversation with The Cancer LetterFree Penn’s Brooks: Surgeons should study oncologic endpoints for years, not just 30-day outcomes April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Conversation with The Cancer LetterFree MD Anderson’s Hunt and Selber: We will study immediate and long-term outcomes of robotic mastectomy in a prospective trial April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Conversation with The Cancer LetterFree MSK’s Kirstein: Robotic mastectomy not demonstrated to be safe for treatment or prevention of breast cancer April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
Free Using a robot to perform mastectomies, a New Jersey surgeon sets off a firestorm over surgical outcomesHow much rigor should be required when surgeons innovate? FDA's advisory asks for long-term cancer-related data April 05, 2019Vol.45 No.14By Matthew Bin Han Ong
FreeGuest Editorial NCCN validates path toward de-escalated doses and reduced costs of cancer drugs March 29, 2019Vol.45 No.13By Allen S. Lichter, Mark J. Ratain, Leonard B. Saltz, Michael Stebbins and David Hyman
FreeTrials & Tribulations SWOG’s 1501 study takes aim at the silo wall between cardiology and oncology March 22, 2019Vol.45 No.12By Justin Floyd
Conversation with The Cancer LetterFree TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?” March 15, 2019Vol.45 No.11By Paul Goldberg
Free Trump proposal for FY2020 to slash NIH by 12 percent, NCI by 15 percent March 15, 2019Vol.45 No.11By Claire Dietz and Matthew Bin Han Ong
FreeGuest Editorial Needed: A fully funded data federation for pediatric cancer with deep genomic sequencing and clinical records March 08, 2019Vol.45 No.10By Nancy Goodman
